Bio-Connect

Anti-CD257 (BAFF) [Tabalumab]

Ab00958-10.0
Absolute Antibody
ApplicationsFunctional Assay, Flow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman, Monkey, Rabbit
TargetTNFSF13B
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Absolute Antibody
  • Product Name
    Anti-CD257 (BAFF) [Tabalumab]
  • Delivery Days Customer
    7
  • Antibody Specificity
    Tabalumab neutralises soluble and membrane-bound BAFF, inhibiting BAFF binding to BR3, TACI and BCMA.
  • Application Supplier Note
    Tabalumab has been tested in patients with systemic lupus erythematosus (Merrill 2015) and in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors (Genovese 2013).
  • Applications
    Functional Assay, Flow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA, Neutralisation/Blocking
  • Applications Supplier
    WB; FC; IP; ELISA; Neutralisation; IF; Functional Studies
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    Tabalumab
  • Gene ID10673
  • Target name
    TNFSF13B
  • Target description
    TNF superfamily member 13b
  • Target synonyms
    ApoL related ligand TALL-1; BAFF; B-cell-activating factor; B-lymphocyte stimulator; BLYS; CD257; delta BAFF; Delta4 BAFF; dendritic cell-derived TNF-like molecule; DTL; epididymis secretory sperm binding protein; TALL1; TALL-1; THANK; TNF and ApoL-related leukocyte expressed ligand 1; TNF homolog that activates apoptosis; TNFSF20; TNLG7A; tumor necrosis factor (ligand) superfamily, member 13b; tumor necrosis factor (ligand) superfamily, member 20; tumor necrosis factor ligand 7A; tumor necrosis factor ligand superfamily member 13B; tumor necrosis factor superfamily member 13b; tumor necrosis factor-like protein ZTNF4; ZTNF4
  • Host
    Human
  • Isotype
    IgG1
  • Protein IDQ9Y275
  • Protein Name
    Tumor necrosis factor ligand superfamily member 13B
  • Scientific Description
    This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques.
  • Reactivity
    Human, Monkey, Rabbit
  • Reactivity Supplier
    Human, Cynomolgus Monkey, Rabbit
  • Reactivity Supplier Note
    Monoclonal antibodies were generated by immunizing human immunoglobulin transgenic mice with soluble human BAFF (amino acids 133–285). Eight mice producing serum antibody titers to human BAFF were injected intravenously with 10 ug human BAFF in phosphate buffered saline. The spleen was harvested 3 days later from each mouse and fused with myeloma cells. 20 Hybridomas were tested for specific binding to human BAFF and to make sure they were expressing human immunoglobulin heavy and light chains by enzyme-linked immunosorbent assay (ELISA). The hybridoma producing the antibody that eventually became tabalumab was a human IgG1 isotype. The antibody was then engineered to a human IgG4 isotype for complete neutralization of BAFF without depletion of BAFF-expressing cells.
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    12352203